OIP5-AS1 has little or non-studies in obesity, whereas GAS5 has been implicated in obesity and insulin resistance by targeting some miRNAs, such as miR-21, that have been implicated in obesity, as well as in lung diseases [26]. Here, OIP5 is linked to lung disorder.